LENZ THERAPEUTICS, INC. (LENZ)

Every figure this model derived for LENZ, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2025-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 511,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 200,269,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 233,282,000 AssetsCurrent 2026-06-30
current liabilities 17,212,000 LiabilitiesCurrent 2026-06-30
equity 219,262,000 StockholdersEquity 2026-06-30
ocf -113,908,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 19,088,000 RevenueFromContractWithCustomerExcludingAssessedTax 2025-12-31
sbc 15,938,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up LENZ on one particular measure came for.

RatioValue
cash operating margin-624.82
current ratio14.2
current ratio reported13.55
dilution pct35.42
fcf margin-599.43
operating margin-710.69
owner earnings margin-682.93
roic-564.26
sbc pct revenue83.5

What to be careful about

What this model itself distrusts about LENZ's figures. Written by the derivation as it ran, not added afterwards.